arrow
M

Michal Sarfaty

rabin medical center
H指数:15
被引数:869

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lutetium-177eprostate-specific membrane antigen (177Lu-PSMA) therapy in patients (pts) with prior Radium-223 (223Ra)

177Lu-PSMA(177镥前列腺特异性膜抗原)疗法在先前接受过镭-223(223Ra)治疗的患者(pts)中的应用

2024-09-010
PRE
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
2023-09-0815
PRE
A first-in-human phase 1 study of LOXO-435, a potent, highly isoform-selective FGFR3 inhibitor in advanced solid tumors with FGFR3 alterations (trial in progress)
2023-04-144
PRE
Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study
2021-03-273
PREAI